Ulta Salon, Cosmetics & Fragrance, Inc.(NASDAQ:ULTA) jumped more than 14% after the company reported late Tuesday Q1 results and guidance that topped expectations. 

Ulta (ULTA) reported Q1 sales of $713.8 million, ahead of the analyst consensus of $699.7 million on Capital IQ. EPS was up 18.5% to $0.77, three cents ahead of expectations. 

For Q2, the company expects sales of $706 to $717 million, vs. Street estimates of $703 million. EPS is seen at $0.78 to $0.83, vs. expectations of $0.82 per share.  In mid-day trade, ULTA was up 14.30% to $97.51. 

Online travel booking site Expedia Inc (NASDAQ:EXPE) said Wednesday it now accepts bitcoin as a form of payment for hotel purchases. ECPE partnered with Coinbase, a third-party bitcoin payment processor, to integrate bitcoin payment support into the hotel-booking experience on Expedia.com. 

Shares are up 1.03% at $75.86 in late-morning trading, with a 52-week range of $45.69 – $81.78.

Jefferies Group analysts have initiated coverage of biopharmaceutical company Regado Biosciences Inc (NASDAQ:RGDO) with a buy rating and a price target of $14 a share. The price target represents a potential upside of 107% from the stock’s current market price.  Shares of RGDO have spiked 4% to $6.75 in morning trading, and move within a 52-week range of $4.27 – $14.10.